Page last updated: 2024-11-03

rabeprazole and Lymphoma, B-Cell

rabeprazole has been researched along with Lymphoma, B-Cell in 1 studies

Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.

Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robotis, J1
Tsiodras, S1
Rokkas, T1

Other Studies

1 other study available for rabeprazole and Lymphoma, B-Cell

ArticleYear
Helicobacter pylori eradication may successfully treat primary cutaneous follicle center lymphoma.
    Helicobacter, 2018, Volume: 23, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Doxycycline; Female; Helicobacter Infec

2018